Allium Group, a Caesarea, Israel start up, has obtained two CE Marks of approval from the European Union bureaucrats to market its biliary and ureteral stents, reports Globes [online].
The company believes its stent technology is far superior to others on the market:
Allium’s thin-walled, large caliber, self-expanding, fully covered metal stents are unique because they can be left in the body for long periods without being changed and easily removed even after long implant periods. Allium’s stents are cost effective and more acceptable to physicians and patients.
The stents developed by Allium are designed to treat malignant as well as benign obstructions. They are engineered to prevent foreshortening during deployment allowing excellent accuracy in their placement and to prevent tissue ingrowth…
Allium’s self-expanding Biliary Stent has a large caliber (8-10mm in diameter) and is made of a superelastic alloy covered by a polymeric material. The stent has a tubular shape to fit the common bile duct anatomy combined with a specially designed proprietary element on its ends to minimize reactive tissue proliferation.
The deployment procedure can be performed using the standard ERCP procedure or percutaneously.
Press release: Allium Group receives CE Marks for two of its next-generation urinary and gastrointestinal-tract stents …
Globes [online]: Allium wins CE Mark for biliary and ureteral stents …
Product pages: Allium’s self-expanding Biliary Stent; Allium’s Ureteral Stent.
